<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Genome-wide association studies have begun to elucidate the genetic architecture of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We examined whether single nucleotide polymorphisms (SNPs) identified through targeted complementary approaches affect <z:mp ids='MP_0002055'>diabetes</z:mp> incidence in the at-risk population of the <z:mp ids='MP_0002055'>Diabetes</z:mp> Prevention Program (DPP) and whether they influence a response to preventive interventions </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We selected SNPs identified by prior genome-wide association studies for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and related traits, or capturing common variation in 40 candidate genes previously associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, implicated in monogenic <z:mp ids='MP_0002055'>diabetes</z:mp>, encoding type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> drug targets or drug-metabolizing/transporting enzymes, or involved in relevant physiological processes </plain></SENT>
<SENT sid="3" pm="."><plain>We analyzed 1,590 SNPs for association with incident <z:mp ids='MP_0002055'>diabetes</z:mp> and their interaction with response to <z:chebi fb="0" ids="6801">metformin</z:chebi> or lifestyle interventions in 2,994 DPP participants </plain></SENT>
<SENT sid="4" pm="."><plain>We controlled for multiple hypothesis testing by assessing false discovery rates </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: We replicated the association of variants in the <z:chebi fb="0" ids="6801">metformin</z:chebi> transporter gene SLC47A1 with <z:chebi fb="0" ids="6801">metformin</z:chebi> response and detected nominal interactions in the <z:chebi fb="47" ids="16027,28971">AMP</z:chebi> kinase (AMPK) gene STK11, the AMPK subunit genes PRKAA1 and PRKAA2, and a missense SNP in SLC22A1, which encodes another <z:chebi fb="0" ids="6801">metformin</z:chebi> transporter </plain></SENT>
<SENT sid="6" pm="."><plain>The most significant association with <z:mp ids='MP_0002055'>diabetes</z:mp> incidence occurred in the AMPK subunit gene PRKAG2 (hazard ratio 1.24, 95% CI 1.09-1.40, P = 7 Ã— 10(-4)) </plain></SENT>
<SENT sid="7" pm="."><plain>Overall, there were nominal associations with <z:mp ids='MP_0002055'>diabetes</z:mp> incidence at 85 SNPs and nominal interactions with the <z:chebi fb="0" ids="6801">metformin</z:chebi> and lifestyle interventions at 91 and 69 mostly nonoverlapping SNPs, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>The lowest P values were consistent with experiment-wide 33% false discovery rates </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: We have identified potential genetic determinants of <z:chebi fb="0" ids="6801">metformin</z:chebi> response </plain></SENT>
<SENT sid="10" pm="."><plain>These results merit confirmation in independent samples </plain></SENT>
</text></document>